top of page
Home
Longevity
About
Career
Contact
More
Use tab to navigate through the menu items.
Diseases
A
B
C
D
E
F
G
H
I J
K
L
M
N
O
P
Q
R
S
T
U
V
W X Y Z
All Posts
Multiple Sclerosis
Ebola Virus disease
Chest Wall Sarcoma
Turner syndrome
Gliomas in Neurofibromatosis
Myasthenia Gravis
Cerebellar Astrocytoma
Brainstem Glioma
Meningioma
Glioblastoma Multiforme
Acoustic Neuroma
Astrocytoma
Paraganglioma
Medulloblastoma
Leptomeningeal disease
Rhinitis
Dementia with Lewy bodies
Neurofibromatosis
Vascular dementia
Autoimmune Myositis
Huntington’s disease
Breast Cancer
Lung cancer
Myocardial Infarction
Multiple myeloma
Eesophageal cancer
Pick’s disease
Gastric cancer
Liver cancer
Optic nerve glioma
4 min read
Can immunotherapy solve the challenges of leptomeningeal disease treatment?
The management of the leptomeningeal disease is complicated with challenges related to the concentration of chemotherapy drugs
4 min read
Cancer vaccine is the next big thing in medulloblastoma treatment: here's why?
Cancer immunotherapy is one of the most promising and fastest-growing areas in cancer research and treatment.
4 min read
Is CX-4945, the next-generation medulloblastoma drug?
Medulloblastoma (MB) is one of the most common types of pediatric brain cancer. It affects children between the ages of 4 to 10 years.
4 min read
Lenvatinib: a breakthrough in unresectable metastatic paraganglioma therapeutics?
Paragangliomas are neuroendocrine tumors that originate from the chromaffin cells of the extra-adrenal paraganglia.
4 min read
Is immunotherapy-a ray of hope for diffuse intrinsic pontine glioma patients?
The advent of immunotherapy is a boon to society. It can suppress the immunity escape and reactivate the antitumor activities.
Collaborators
Get new content delivered directly to your inbox.
Subscribe Now
bottom of page
